Skip to main content

Health and Medicine

Stopping colitis, STAT

Oct. 27, 2011—Study suggests a new therapeutic target in ulcerative colitis.

Read more


Growth factor boosts beta cells

Oct. 21, 2011—A growth factor may help grow transplantation-quality pancreas cells for treating diabetes.

Read more


Information flow reduced in psychosis

Oct. 21, 2011—Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows.

Read more


Initiative to help ‘translate’ diabetes research advances

Oct. 21, 2011—The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home.

Read more


Predicting hospital readmission is risky business: study

Oct. 18, 2011—Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.

Read more


Supplements don’t help lung injury patients

Oct. 13, 2011—Supplements did not improve outcomes of patients with acute lung injury.

Read more


Diversity key in antibody repertoire

Oct. 7, 2011—Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

Read more


Fungus toxin gets in the way in DNA

Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.

Read more


Heart protein may be target for colon cancer therapies

Oct. 7, 2011—A protein critical in heart development may also play a part in colon cancer progression.

Read more


Parkinson’s deep brain target fired up

Oct. 5, 2011—Neuronal activity in a deep brain region increases as Parkinson’s disease advances, a new study suggests.

Read more


Drug-like molecules aimed at improving treatment of Parkinson’s

Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.

Read more


Folate may lower breast cancer risk for some

Sep. 29, 2011—Low folate levels may increase a premenopausal woman’s risk of developing breast cancer.

Read more


Upcoming Events

MORE EVENTS »